CCRCC
Clinical trials for CCRCC explained in plain language.
Never miss a new study
Get alerted when new CCRCC trials appear
Sign up with your email to follow new studies for CCRCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation zaps recurrent kidney cancer in major new trial
Disease control Not yet recruitingThis study is testing a new targeted radiation drug called 177Lu-TLX250 for people with advanced kidney cancer that has returned or spread after at least two prior treatments. The drug is designed to find and deliver radiation directly to cancer cells. The trial will first find t…
Matched conditions: CCRCC
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for kidney cancer patients when first treatment fails
Disease control Not yet recruitingThis study is for people with advanced clear-cell kidney cancer that has come back after they received a specific immunotherapy drug (pembrolizumab) as a preventative treatment after surgery. It aims to see if combining that same immunotherapy with a different drug (lenvatinib) c…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New scan aims to spot hidden kidney cancer
Diagnosis Not yet recruitingThis study is testing a new type of PET scan to see if it can better detect leftover or returning kidney cancer after a patient's initial treatment. Researchers will give participants a special imaging drug and then perform scans to see if the cancer lights up. The goal is to imp…
Matched conditions: CCRCC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC